Today
Mithra Pharmaceuticals is pursuing its major R&D projects and is strengthening its activities initiated in each of the earlier phases.
In the third phase of the development of Mithra Pharmaceuticals, starting in 2014, the company added a focus on innovation and development, spearheaded by its development of Estetrol in contraception and menopause, and its development of complex therapeutics. This third phase is currently ongoing.
In the second phase, as from 2004, Mithra Pharmaceuticals began developing its first generic hormonal drugs and focusing on the commercialisation of its branded generics, which allowed it to build up its business development organisation and become recognized, both in Benelux and internationally, as a specialist in the women’s health care sector having a very strong know-how in the development of complex products.
The first phase began in 1999 when Mithra Pharmaceuticals was founded by entrepreneur François Fornieri and Prof. Dr. Foidart, as a spin-off of the University of Liège.
The Company began by targeting gynecologists with a range of personal hygiene products, food supplements, medical devices and over-the-counter products, an initial product range enabling the new company to build up a reputation with professionals in the Women’s Health sector, and working with established pharmaceutical groups in the launch of their new products in this sector in Belgium.